Skip to main content

After the diagnosis

Cancer surveillance MRI: how follow-up scans actually work (2026 UK guide)

After a cancer diagnosis, MRI is often part of the follow-up schedule for years. The frequency, protocol and threshold for action are not obvious to patients. This is how surveillance MRI actually works - what changes on the scan matter, how the intervals are set, and what to expect from each visit.

By The Pulse Atlas Editorial Team

10 min read · 30 August 2026

A patient walking through a hospital corridor before a follow-up scan
The corridor between scans. Illustrative image.

A cancer diagnosis does not end at treatment. For most people it opens a long, quiet chapter of surveillance - MRI scans at set intervals, for years, sometimes for life. The scans matter. The intervals matter. And nobody sits you down to explain how any of it actually works, why your first year of follow-up looks nothing like your fifth, or what the words "stable disease" and "no new lesions" really mean when you read them on your report.

This piece is written for patients living inside that chapter. It is about surveillance MRI in the UK in 2026 - the protocols, the schedules, the thresholds that trigger action, and the things a good MRI service should give you at every follow-up visit.

The one-line answer

Surveillance MRI is a planned series of scans, at intervals set by your cancer team, whose only job is to catch recurrence or progression early enough to change what happens next. It is not a general health check. Every image is compared to every image before it, and the report reads change - not a snapshot.

Why surveillance MRI exists

The blunt reason is that recurrence is often silent. Many cancers return quietly, without symptoms, in the months and years after the primary treatment is finished. By the time a person notices, the disease has usually moved from something small and local to something larger and harder to treat. Surveillance imaging exists to close that gap.

There are three distinct clinical reasons your oncologist keeps you on a scan schedule. First, early detection of recurrence - finding a new lesion when it is one centimetre and treatable, not when it is symptomatic. Second, disease modification - some cancers, particularly slow-growing prostate, low-grade glioma and certain sarcomas, live on active surveillance, where the scan is the decision-making tool for when to intervene at all. Third, changing treatment before symptoms return - a rising area of change on MRI often triggers a switch of systemic therapy weeks or months before the patient would have felt anything, and those weeks can matter.

The unglamorous truth is that most surveillance scans are normal. That is the point. You are buying certainty, cheaply, at the price of an hour on a scanner every few months.

Common cancer surveillance MRI protocols

Every cancer has its own surveillance rhythm, and it is worth knowing yours in some detail. A few of the most common in UK practice:

CancerTypical MRI protocolBaseline schedule
High-risk breast (BRCA, dense breast, prior DCIS)Annual bilateral breast MRI with contrast, paired with mammographyAnnual, indefinite
Prostate on active surveillancempMRI (T2, DWI, dynamic contrast)12 months, then 36 months, then triggered by PSA
Post-glioma brainContrast-enhanced brain MRI with perfusion3-monthly year 1, 6-monthly years 2 to 5, annual after
Hepatocellular carcinoma (post-resection or post-ablation)Multiphase liver MRI with gadoxetate3-monthly year 1, 6-monthly thereafter
Soft-tissue sarcomaLocal-site MRI with contrast, plus chest CT3 to 6-monthly years 1 to 3, then annual
Rectal cancer post-treatmentPelvic MRI with DWI6-monthly years 1 to 2, then annual

These are typical UK practice patterns, not personal advice. Your own schedule is set by your oncologist and multi-disciplinary team on the basis of tumour biology, treatment received and personal risk factors.

What a "stable" report actually means

Radiologists reporting oncology follow-up almost always use a formal scoring system called RECIST 1.1, and understanding it removes most of the anxiety around the wording of your report.

RECIST measures the longest diameter of up to five "target lesions" - the pieces of disease chosen at baseline as representative. Every subsequent scan re-measures those same lesions, and the numbers are added up.

  • Complete response: all target lesions gone.
  • Partial response: the sum has decreased by 30 per cent or more.
  • Stable disease: neither of the above, and no new lesion. This is the report most surveillance patients receive.
  • Progressive disease: a 20 per cent increase in the sum of measurements, or any new lesion of significance.

A "stable" report is genuinely good news. It does not mean the disease is cured, and it does not mean it will always be stable, but on this particular scan, at this particular interval, the pattern is holding. That is what surveillance is designed to confirm.

An MRI scanner room prepared for a surveillance appointment
A scanner room set up for a follow-up study. Illustrative image.

The "suspicious for progression" report

Occasionally the report reads less reassuringly. A target lesion has grown by more than the RECIST threshold. A new small area of enhancement has appeared where nothing was before. The radiologist writes "suspicious for progression" or "concerning for recurrence".

This is not a diagnosis of anything on its own. It is a signal that triggers a specific set of next steps, and knowing them ahead of time is worth a great deal.

  • Short-interval repeat scan. Very common. Six to eight weeks later, the same protocol, to see whether the finding is real, artefactual, or inflammatory rather than tumour.
  • Targeted biopsy. If the finding is accessible and the imaging is convincing, the multi-disciplinary team may proceed directly to a biopsy of the new area.
  • Change of therapy. For patients already on systemic treatment, radiological progression is often the trigger for switching to the next line of therapy without waiting for symptoms.
  • Correlation with tumour markers. PSA, CA-125, CEA and others are checked in parallel with the scan.

A well-run oncology service will call you with the plan, not the finding. If the plan is "let us repeat in six weeks", that is genuinely a common and appropriate response - it is not the team hiding worse news.

Frequency: when scans get further apart

Most surveillance schedules follow the same broad shape. Scans are close together at the start, when the risk of early recurrence is highest, and space out as time passes and risk falls.

  • Year 1: often 3-monthly, sometimes with different modalities alternating.
  • Years 2 to 3: typically 6-monthly.
  • Years 3 to 5: annual for most cancers.
  • After year 5: annual, or discharged to your GP, depending on cancer type and personal risk profile.

The rhythm is not arbitrary. Recurrence curves for most solid tumours are front-loaded, and the intervals track the residual statistical risk at each point in time. That is why year one feels intense and year five feels almost like normal life again.

How Pulse Atlas books surveillance MRIs privately

Surveillance imaging is one of the few areas where paying privately genuinely changes the experience, not just the wait. Three things matter more here than for one-off diagnostic scans.

First, the same radiologist. Comparison is the whole product of a surveillance MRI. A radiologist who has read your baseline, your year-one and your year-two scans will see subtle change that a first-time reader may not. Private practice can arrange this. NHS services are working towards it but cannot always guarantee it.

Second, direct oncologist link. A good private service sends the report and images to your treating oncologist within 48 hours of the scan, with a clear line of communication if the report needs discussion. You do not lose weeks in postal referrals.

Third, continuity of scanner and protocol. Small differences in scanner make, sequence timing or contrast injection speed all move measurements by a few millimetres. Being scanned on the same machine with the same protocol every time removes most of that noise. It sounds trivial. On a RECIST calculation, it is not.

What to expect on the day

Practically, a surveillance MRI is very similar visit to visit. You arrive around 20 minutes before the scan. A cannula goes into the back of your hand for gadolinium contrast. You change into a gown and remove any metal. You lie on the table, and for the next 25 to 55 minutes you stay still while the scanner works through its sequences. The noise is loud but predictable. Headphones and music are standard.

The images are read within 24 to 48 hours in private practice, and typically within two to three weeks on the NHS unless flagged as urgent. The report reaches your oncologist, who reads it against your history and calls or writes to you with a plan. If nothing has changed, the next appointment goes in the diary. If something has, the plan explains what happens next.

You are not expected to interpret the raw report yourself. If you receive a copy and something in it worries you, ring your specialist nurse - that is exactly what the line is for. Do not sit alone at home with a report open.

For patients weighing up how to fit surveillance imaging into a busy life, or how to combine it with existing NHS oncology care, our team at Pulse Atlas find care can help you build a schedule that works. The scans are only useful if they actually happen, on time, year after year.

Common questions

FAQs

Can I have the same radiologist read every surveillance MRI?

In private practice yes, and it genuinely helps. Comparison is the whole point of surveillance imaging, and a radiologist who has read your previous scans spots subtle change faster than a first-time reader. In the NHS this is harder to guarantee, though the report itself always compares to the prior study.

How much does a cancer surveillance MRI cost in the UK?

All-in prices in 2026 range from £550 to £950 for a single region surveillance MRI, and £900 to £1,600 for multi-region protocols such as breast plus axilla or whole-liver. Contrast is usually included. See our full 2026 price breakdown.

Can I mix NHS treatment with private surveillance scans?

Yes, and many patients do. A private surveillance MRI with the report sent to your NHS oncologist keeps your treatment pathway free of charge on the NHS while removing the wait for imaging. Reputable providers send images and report directly to your consultant.

How does RECIST work?

RECIST is the international scoring system radiologists use to judge whether cancer has grown, shrunk or stayed stable between scans. It measures the longest diameter of up to five target lesions. Progression is a 20 per cent increase in the sum of those measurements, or any new lesion. Partial response is a 30 per cent decrease. Anything in between is stable disease.

Do I need contrast every time?

Usually yes for oncology surveillance. Gadolinium contrast lets the radiologist see the vascular pattern of a lesion, which is often the earliest sign of recurrence. Some protocols, such as prostate active surveillance, may drop contrast on later scans if the baseline is well characterised.

How long does a surveillance MRI take?

Between 25 and 55 minutes on the scanner, depending on the protocol. Breast surveillance MRI is around 30 minutes, prostate mpMRI 35 to 45, and multi-region liver or pelvis 45 to 55. Add 15 minutes at each end for cannulation and gowning.

What happens if I miss a surveillance appointment?

Nothing catastrophic if you rebook within a few weeks. Surveillance intervals are chosen with some tolerance built in. Tell your oncology team, ask to be rebooked at the front of the next available list, and do not silently drop out of the schedule. Continuity of comparison matters more than hitting an exact date.

Written by

The Pulse Atlas Editorial Team

This is our editorial team, in charge of researching, editing and reviewing every blog we publish. Each piece is put together from the most recent public research on how the UK healthcare industry actually works in 2026 - private clinics, NHS wait times, insurer behaviour and patient experience.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.